On-Air Now
On-Air Now

Big pharma deal: Bristol-Myers Squibb to buy Celgene

By

/

Drugmaker Bristol-Myers Squibb announced a $74 billion deal to buy Celgene, in one of the biggest mergers in pharmaceutical industry history.

[van id=”business/2019/01/03/bristol-myers-squibb-celgene-merger.cnn-business”]